[Clinical trials in various dermatoses, with a new topical corticoid-anti-infective agent combination].
D000293:Adolescent; D000328:Adult; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage*; D001623:Betamethasone / Q000008:administration & dosage* / Q000627:therapeutic use; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006912:Hydroxyquinolines / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009824:Ointments; D012871:Skin Diseases / Q000188:drug therapy*; D014047:Tolnaftate / Q000008:administration & dosage / Q000627:therapeutic use
D000891:Anti-Infective Agents, Local; D004338:Drug Combinations; D005839:Gentamicins; D006912:Hydroxyquinolines; D009824:Ointments; D014047:Tolnaftate; D001623:Betamethasone
Ensayo clínico en diversas dermatosis, con una nueva asociación corticoide-anti-infecciosa en aplicación tópica